Earnings Summary

Bruker Corporation’s revenue jumped 16.37% since last year same period to $864.4Mn in the Q3 2024. On a quarterly growth basis, Bruker Corporation has generated 7.96% jump in its revenue since last 3-months.

Bruker Corporation’s net profit fell -53.58% since last year same period to $40.9Mn in the Q3 2024. On a quarterly growth basis, Bruker Corporation has generated 438.16% jump in its net profits since last 3-months.

Bruker Corporation’s net profit margin fell -60.11% since last year same period to 4.73% in the Q3 2024. On a quarterly growth basis, Bruker Corporation has generated 398.5% jump in its net profit margins since last 3-months.

Bruker Corporation’s price-to-earnings ratio after this Q3 2024 earnings stands at 23.31.

Bruker Corporation’s earning per share (EPS) estimates for the current quarter stand at 0.59 - a 13.46% jump from last quarter’s estimates.

Bruker Corporation’s earning per share (EPS) estimates for the current year stand at 0.59.

Bruker Corporation’s earning per share (EPS) fell -18.92% since last year same period to 0.6 in the Q3 2024. This indicates that the Bruker Corporation has generated -18.92% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bruker Corporation’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bruker Corporation’s return on equity (ROE) stands at 0.2.

Bruker Corporation declared 0.05 dividend per share during the earnings announcement for Q3 2024.